TreeWAS – Variant ID: rs17415601

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
L40.9 Psoriasis, unspecified	1.000	0.000
L40 Psoriasis	1.000	0.000
# Top node	1.000	0.000
Chapter VI Diseases of the nervous system	1.000	0.000
L40.5 Arthropathic psoriasis	1.000	0.000
Chapter XIX Injury, poisoning and certain other consequences of external causes	1.000	0.000
Chapter XII Diseases of the skin and subcutaneous tissue	1.000	0.000
L40-L45 Papulosquamous disorders	1.000	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	1.000	0.000
Chapter II Neoplasms	1.000	0.000
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.998	0.002
Chapter V Mental and behavioural disorders	0.997	0.003
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.996	0.004
F30-F39 Mood [affective] disorders	0.991	0.009
G35-G37 Demyelinating diseases of the central nervous system	0.989	0.011
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.982	0.018
M86-M90 Other osteopathies	0.977	0.023
C79 Secondary malignant neoplasm of other sites	0.973	0.027
G40-G47 Episodic and paroxysmal disorders	0.971	0.029
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.970	0.030
L57 Skin changes due to chronic exposure to nonionising radiation	0.969	0.031
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.967	0.033
Chapter XX External causes of morbidity and mortality	0.967	0.033
G40 Epilepsy	0.962	0.038
G35 Multiple sclerosis	0.962	0.038
D00-D09 In situ neoplasms	0.962	0.038
M05-M14 Inflammatory polyarthropathies	0.960	0.040
C15-C26 Malignant neoplasms of digestive organs	0.956	0.044
L57.0 Actinic keratosis	0.951	0.049
M07 Psoriatic and enteropathic arthropathies	0.951	0.049
C78.7 Secondary malignant neoplasm of liver	0.946	0.054
M70-M79 Other soft tissue disorders	0.945	0.055
M07.3 Other psoriatic arthropathies	0.945	0.055
F31 Bipolar affective disorder	0.942	0.058
W20-W49 Exposure to inanimate mechanical forces	0.942	0.058
M89 Other disorders of bone	0.938	0.062
F32 Depressive episode	0.929	0.071
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.925	0.075
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.925	0.075
G30-G32 Other degenerative diseases of the nervous system	0.918	0.082
S40-S49 Injuries to the shoulder and upper arm	0.918	0.082
C79.7 Secondary malignant neoplasm of adrenal gland	0.918	0.082
W22 Striking against or struck by other objects	0.912	0.088
G37 Other demyelinating diseases of central nervous system	0.911	0.089
F30 Manic episode	0.909	0.091
M07.30 Other psoriatic arthropathies (Multiple sites)	0.906	0.094
G20-G26 Extrapyramidal and movement disorders	0.904	0.096
T43.2 Other and unspecified antidepressants	0.904	0.096
T15-T19 Effects of foreign body entering through natural orifice	0.902	0.098
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.902	0.098
G40.9 Epilepsy, unspecified	0.900	0.100
G70-G73 Diseases of myoneural junction and muscle	0.894	0.106
T46 Poisoning by agents primarily affecting the cardiovascular system	0.891	0.109
W22.9 Unspecified place	0.891	0.109
M07.39 Other psoriatic arthropathies (Site unspecified)	0.889	0.111
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.889	0.111
M77 Other enthesopathies	0.889	0.111
M89.9 Disorder of bone, unspecified	0.888	0.112
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.886	0.114
M60-M63 Disorders of muscles	0.885	0.115
M45-M49 Spondylopathies	0.880	0.120
C18 Malignant neoplasm of colon	0.879	0.121
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.877	0.123
D05 Carcinoma in situ of breast	0.874	0.126
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.874	0.126
S60-S69 Injuries to the wrist and hand	0.871	0.129
C43-C44 Melanoma and other malignant neoplasms of skin	0.865	0.135
C79.8 Secondary malignant neoplasm of other specified sites	0.864	0.136
X60-X84 Intentional self-harm	0.862	0.138
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.859	0.141
L40.0 Psoriasis vulgaris	0.854	0.146
T43.3 Phenothiazine antipsychotics and neuroleptics	0.854	0.146
M79 Other soft tissue disorders, not elsewhere classified	0.850	0.150
M10 Gout	0.850	0.150
F31.0 Bipolar affective disorder, current episode hypomanic	0.847	0.153
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.847	0.153
D07 Carcinoma in situ of other and unspecified genital organs	0.846	0.154
G62 Other polyneuropathies	0.845	0.155
C64-C68 Malignant neoplasms of urinary tract	0.841	0.159
M87 Osteonecrosis	0.839	0.161
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.839	0.161
D04 Carcinoma in situ of skin	0.838	0.162
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.837	0.163
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.836	0.164
S62 Fracture at wrist and hand level	0.835	0.165
G70 Myasthenia gravis and other myoneural disorders	0.834	0.166
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.833	0.167
G37.9 Demyelinating disease of central nervous system, unspecified	0.833	0.167
M91-M94 Chondropathies	0.832	0.168
S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle	0.831	0.169
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.830	0.170
F40-F48 Neurotic, stress-related and somatoform disorders	0.828	0.172
T42.4 Benzodiazepines	0.828	0.172
W50-W64 Exposure to animate mechanical forces	0.827	0.173
C44 Other malignant neoplasms of skin	0.825	0.175
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.823	0.177
M46 Other inflammatory spondylopathies	0.822	0.178
D05.9 Carcinoma in situ of breast, unspecified	0.821	0.179
T18 Foreign body in alimentary tract	0.819	0.181
W44 Foreign body entering into or through eye or natural orifice	0.818	0.182
F30.2 Mania with psychotic symptoms	0.815	0.185
C78.2 Secondary malignant neoplasm of pleura	0.814	0.186
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.813	0.187
M89.94 Disorder of bone, unspecified (Hand)	0.812	0.188
C78.4 Secondary malignant neoplasm of small intestine	0.812	0.188
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.810	0.190
G63 Polyneuropathy in diseases classified elsewhere	0.810	0.190
F32.0 Mild depressive episode	0.807	0.193
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.806	0.194
M62 Other disorders of muscle	0.804	0.196
S10-S19 Injuries to the neck	0.798	0.202
C26 Malignant neoplasm of other and ill-defined digestive organs	0.797	0.203
T39.1 4-Aminophenol derivatives	0.796	0.204
T36 Poisoning by systemic antibiotics	0.796	0.204
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.795	0.205
M00-M03 Infectious arthropathies	0.792	0.208
F60-F69 Disorders of adult personality and behaviour	0.791	0.209
M07.36 Other psoriatic arthropathies (Lower leg)	0.791	0.209
G70.0 Myasthenia gravis	0.791	0.209
G41 Status epilepticus	0.791	0.209
S90-S99 Injuries to the ankle and foot	0.787	0.213
C17 Malignant neoplasm of small intestine	0.786	0.214
F32.9 Depressive episode, unspecified	0.783	0.217
C18.9 Colon, unspecified	0.782	0.218
Y57 Other and unspecified drugs and medicaments	0.782	0.218
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.778	0.222
G25 Other extrapyramidal and movement disorders	0.778	0.222
C18.6 Descending colon	0.778	0.222
C19 Malignant neoplasm of rectosigmoid junction	0.777	0.223
S43.0 Dislocation of shoulder joint	0.777	0.223
G31.9 Degenerative disease of nervous system, unspecified	0.776	0.224
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.776	0.224
C44.3 Skin of other and unspecified parts of face	0.773	0.227
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.773	0.227
G40.7 Petit mal, unspecified, without grand mal seizures	0.772	0.228
S63 Dislocation, sprain and strain of joints and ligaments at wrist and hand level	0.771	0.229
M10.9 Gout, unspecified	0.771	0.229
G62.9 Polyneuropathy, unspecified	0.767	0.233
F80-F89 Disorders of psychological development	0.765	0.235
M46.9 Inflammatory spondylopathy, unspecified	0.762	0.238
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.761	0.239
M79.1 Myalgia	0.761	0.239
M77.1 Lateral epicondylitis	0.758	0.242
M77.0 Medial epicondylitis	0.758	0.242
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.756	0.244
Chapter XIV Diseases of the genitourinary system	0.755	0.245
T20-T25 Burns and corrosions of external body surface, specified by site	0.755	0.245
C02 Malignant neoplasm of other and unspecified parts of tongue	0.755	0.245
G24 Dystonia	0.754	0.246
X50-X57 Overexertion, travel and privation	0.754	0.246
M79.0 Rheumatism, unspecified	0.753	0.247
F99-F99 Unspecified mental disorder	0.752	0.248
C44.7 Skin of lower limb, including hip	0.751	0.249
M71 Other bursopathies	0.749	0.251
F32.1 Moderate depressive episode	0.747	0.252
M62.8 Other specified disorders of muscle	0.747	0.253
F30.9 Manic episode, unspecified	0.746	0.253
F39 Unspecified mood [affective] disorder	0.746	0.254
F32.2 Severe depressive episode without psychotic symptoms	0.746	0.254
Y57.9 Drug or medicament, unspecified	0.746	0.254
G00-G09 Inflammatory diseases of the central nervous system	0.746	0.254
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.745	0.255
M40-M43 Deforming dorsopathies	0.745	0.255
T43.4 Butyrophenone and thioxanthene neuroleptics	0.743	0.257
T45.0 Antiallergic and antiemetic drugs	0.743	0.257
M90 Osteopathies in diseases classified elsewhere	0.743	0.257
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.742	0.258
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.742	0.258
N10-N16 Renal tubulo-interstitial diseases	0.740	0.260
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.739	0.261
M89.8 Other specified disorders of bone	0.738	0.262
S62.6 Fracture of other finger	0.738	0.262
N13 Obstructive and reflux uropathy	0.737	0.263
T47.1 Other antacids and anti-gastric-secretion drugs	0.737	0.263
M89.3 Hypertrophy of bone	0.735	0.265
M86 Osteomyelitis	0.735	0.265
C77.1 Intrathoracic lymph nodes	0.735	0.265
C06 Malignant neoplasm of other and unspecified parts of mouth	0.734	0.266
N20-N23 Urolithiasis	0.733	0.267
F00-F09 Organic, including symptomatic, mental disorders	0.732	0.268
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.731	0.268
G31.8 Other specified degenerative diseases of nervous system	0.731	0.269
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.730	0.269
S31 Open wound of abdomen, lower back and pelvis	0.730	0.270
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.729	0.271
W44.0 Home	0.729	0.271
S42 Fracture of shoulder and upper arm	0.728	0.272
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system	0.728	0.272
G63.2 Diabetic polyneuropathy	0.728	0.272
T18.1 Foreign body in oesophagus	0.726	0.274
X10-X19 Contact with heat and hot substances	0.726	0.274
Chapter XXII Codes for special purposes	0.724	0.276
M79.2 Neuralgia and neuritis, unspecified	0.723	0.277
T46.4 Angiotensin-converting-enzyme inhibitors	0.722	0.278
G44 Other headache syndromes	0.722	0.278
W23 Caught, crushed, jammed or pinched in or between objects	0.721	0.279
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.721	0.279
D07.5 Prostate	0.718	0.282
L40.8 Other psoriasis	0.717	0.283
L40.4 Guttate psoriasis	0.717	0.283
L40.3 Pustulosis palmaris et plantaris	0.717	0.283
L40.2 Acrodermatitis continua	0.717	0.283
L40.1 Generalised pustular psoriasis	0.717	0.283
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283
L10-L14 Bullous disorders	0.717	0.283
T33-T35 Frostbite	0.717	0.283
T26-T28 Burns and corrosions confined to eye and internal organs	0.717	0.283
T00-T07 Injuries involving multiple body regions	0.717	0.283
L44 Other papulosquamous disorders	0.717	0.283
L41 Parapsoriasis	0.717	0.283
L45 Papulosquamous disorders in diseases classified elsewhere	0.717	0.283
L42 Pityriasis rosea	0.717	0.283
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.717	0.283
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.717	0.283
T41 Poisoning by anaesthetics and therapeutic gases	0.717	0.283
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.717	0.283
C40-C41 Malignant neoplasms of bone and articular cartilage	0.717	0.283
F31.9 Bipolar affective disorder, unspecified	0.716	0.284
C18.7 Sigmoid colon	0.715	0.285
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.715	0.285
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.715	0.285
F70-F79 Mental retardation	0.715	0.285
M77.9 Enthesopathy, unspecified	0.714	0.286
C76 Malignant neoplasm of other and ill-defined sites	0.714	0.286
X58-X59 Accidental exposure to other and unspecified factors	0.714	0.286
D04.5 Skin of trunk	0.714	0.286
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.714	0.286
T45.2 Vitamins, not elsewhere classified	0.714	0.286
F38 Other mood [affective] disorders	0.711	0.289
F34 Persistent mood [affective] disorders	0.711	0.289
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.710	0.290
G36 Other acute disseminated demyelination	0.709	0.291
S49 Other and unspecified injuries of shoulder and upper arm	0.708	0.292
N20 Calculus of kidney and ureter	0.707	0.293
Y00-Y09 Assault	0.706	0.294
G62.0 Drug-induced polyneuropathy	0.706	0.294
M76 Enthesopathies of lower limb, excluding foot	0.706	0.294
M79.7 Fibromyalgia	0.706	0.294
M95-M99 Other disorders of the musculoskeletal system and connective tissue	0.705	0.294
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.705	0.295
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.705	0.295
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.705	0.295
M87.9 Osteonecrosis, unspecified	0.705	0.295
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.704	0.296
L58 Radiodermatitis	0.704	0.296
L56 Other acute skin changes due to ultraviolet radiation	0.704	0.296
L55 Sunburn	0.704	0.296
M72 Fibroblastic disorders	0.704	0.296
S00-S09 Injuries to the head	0.704	0.296
M47 Spondylosis	0.703	0.297
Y60-Y69 Misadventures to patients during surgical and medical care	0.703	0.297
L80-L99 Other disorders of the skin and subcutaneous tissue	0.702	0.298
S92 Fracture of foot, except ankle	0.702	0.298
M80-M85 Disorders of bone density and structure	0.700	0.299
T43.5 Other and unspecified antipsychotics and neuroleptics	0.700	0.300
S41 Open wound of shoulder and upper arm	0.700	0.300
F23 Acute and transient psychotic disorders	0.700	0.300
C20 Malignant neoplasm of rectum	0.698	0.302
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.697	0.302
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.697	0.303
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.697	0.303
T50.9 Other and unspecified drugs, medicaments and biological substances	0.696	0.304
G46 Vascular syndromes of brain in cerebrovascular diseases	0.696	0.304
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.696	0.304
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.696	0.304
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.695	0.305
T39.0 Salicylates	0.695	0.305
T46.1 Calcium-channel blockers	0.695	0.305
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.695	0.305
L57.5 Actinic granuloma	0.695	0.305
L57.4 Cutis laxa senilis	0.695	0.305
L57.3 Poikiloderma of Civatte	0.695	0.305
L57.2 Cutis rhomboidalis nuchae	0.695	0.305
L57.1 Actinic reticuloid	0.695	0.305
N20.1 Calculus of ureter	0.695	0.305
T43.9 Psychotropic drug, unspecified	0.694	0.306
T43.8 Other psychotropic drugs, not elsewhere classified	0.694	0.306
T43.6 Psychostimulants with abuse potential	0.694	0.306
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.694	0.306
Y35-Y36 Legal intervention and operations of war	0.693	0.307
Y10-Y34 Event of undetermined intent	0.693	0.307
X85-X99 Assault	0.693	0.307
X30-X39 Exposure to forces of nature	0.693	0.307
X00-X09 Exposure to smoke, fire and flames	0.693	0.307
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.693	0.307
W75-W84 Other accidental threats to breathing	0.693	0.307
W65-W74 Accidental drowning and submersion	0.693	0.307
V98-V99 Other and unspecified transport accidents	0.693	0.307
V95-V97 Air and space transport accidents	0.693	0.307
V90-V94 Water transport accidents	0.693	0.307
V70-V79 Bus occupant injured in transport accident	0.693	0.307
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.693	0.307
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.693	0.307
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.693	0.307
V01-V09 Pedestrian injured in transport accident	0.693	0.307
M10.99 Gout, unspecified (Site unspecified)	0.693	0.307
F40 Phobic anxiety disorders	0.693	0.307
S62.3 Fracture of other metacarpal bone	0.692	0.308
M88 Paget's disease of bone [osteitis deformans]	0.692	0.308
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)	0.691	0.309
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.691	0.309
D07.1 Vulva	0.691	0.309
T45.1 Antineoplastic and immunosuppressive drugs	0.690	0.310
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.690	0.310
G40.4 Other generalised epilepsy and epileptic syndromes	0.690	0.310
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.690	0.310
D02 Carcinoma in situ of middle ear and respiratory system	0.689	0.311
D01 Carcinoma in situ of other and unspecified digestive organs	0.689	0.311
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.689	0.311
S46 Injury of muscle and tendon at shoulder and upper arm level	0.689	0.311
M12 Other specific arthropathies	0.688	0.312
M09 Juvenile arthritis in diseases classified elsewhere	0.688	0.312
M08 Juvenile arthritis	0.688	0.312
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.686	0.314
C91 Lymphoid leukaemia	0.686	0.314
D04.4 Skin of scalp and neck	0.686	0.314
C23 Malignant neoplasm of gallbladder	0.686	0.314
V20-V29 Motorcycle rider injured in transport accident	0.685	0.315
V10-V19 Pedal cyclist injured in transport accident	0.685	0.315
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.685	0.315
C12 Malignant neoplasm of pyriform sinus	0.684	0.315
C66 Malignant neoplasm of ureter	0.683	0.317
C26.0 Intestinal tract, part unspecified	0.683	0.317
V40-V49 Car occupant injured in transport accident	0.683	0.317
M47.8 Other spondylosis	0.682	0.318
S80-S89 Injuries to the knee and lower leg	0.682	0.318
W57 Bitten or stung by non-venomous insect and other non-venomous arthropods	0.682	0.318
M07.6 Other enteropathic arthropathies	0.682	0.318
M07.5 Arthropathy in ulcerative colitis	0.682	0.318
M07.4 Arthropathy in Crohn's disease [regional enteritis]	0.682	0.318
M07.2 Psoriatic spondylitis	0.682	0.318
M07.1 Arthritis mutilans	0.682	0.318
M07.0 Distal interphalangeal psoriatic arthropathy	0.682	0.318
D04.6 Skin of upper limb, including shoulder	0.680	0.320
M14 Arthropathies in other diseases classified elsewhere	0.680	0.320
C18.1 Appendix	0.680	0.320
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.680	0.320
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.680	0.320
L81 Other disorders of pigmentation	0.680	0.320
D03 Melanoma in situ	0.680	0.320
X78 Intentional self-harm by sharp object	0.679	0.321
M73 Soft tissue disorders in diseases classified elsewhere	0.677	0.322
S67 Crushing injury of wrist and hand	0.677	0.323
M07.38 Other psoriatic arthropathies (Other)	0.677	0.323
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.677	0.323
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.677	0.323
M07.34 Other psoriatic arthropathies (Hand)	0.677	0.323
M07.33 Other psoriatic arthropathies (Forearm)	0.677	0.323
M07.32 Other psoriatic arthropathies (Upper arm)	0.677	0.323
M07.31 Other psoriatic arthropathies (Shoulder region)	0.677	0.323
F31.8 Other bipolar affective disorders	0.676	0.324
F31.7 Bipolar affective disorder, currently in remission	0.676	0.324
F31.6 Bipolar affective disorder, current episode mixed	0.676	0.324
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.676	0.324
W46 Contact with hypodermic needle	0.675	0.324
W45 Foreign body or object entering through skin	0.675	0.324
W43 Exposure to vibration	0.675	0.324
W42 Exposure to noise	0.675	0.324
W41 Exposure to high-pressure jet	0.675	0.324
W40 Explosion of other materials	0.675	0.324
W39 Discharge of firework	0.675	0.324
W38 Explosion and rupture of other specified pressurised devices	0.675	0.324
W37 Explosion and rupture of pressurised tyre, pipe or hose	0.675	0.324
W36 Explosion and rupture of gas cylinder	0.675	0.324
W35 Explosion and rupture of boiler	0.675	0.324
W34 Discharge from other and unspecified firearms	0.675	0.324
W33 Rifle, shotgun and larger firearm discharge	0.675	0.324
W32 Handgun discharge	0.675	0.324
W31 Contact with other and unspecified machinery	0.675	0.324
W30 Contact with agricultural machinery	0.675	0.324
W28 Contact with powered lawn mower	0.675	0.324
W27 Contact with nonpowered hand tool	0.675	0.324
W26 Contact with knife, sword or dagger	0.675	0.324
W24 Contact with lifting and transmission devices, not elsewhere classified	0.675	0.324
W20 Struck by thrown, projected or falling object	0.675	0.324
S32 Fracture of lumbar spine and pelvis	0.675	0.325
C18.5 Splenic flexure	0.674	0.326
X40-X49 Accidental poisoning by and exposure to noxious substances	0.674	0.326
G40.5 Special epileptic syndromes	0.673	0.327
W29 Contact with other powered hand tools and household machinery	0.673	0.327
S37 Injury of urinary and pelvic organs	0.673	0.327
C78.1 Secondary malignant neoplasm of mediastinum	0.673	0.327
T42.1 Iminostilbenes	0.673	0.327
M89.6 Osteopathy after poliomyelitis	0.672	0.328
M89.5 Osteolysis	0.672	0.328
M89.4 Other hypertrophic osteo-arthropathy	0.672	0.328
M89.2 Other disorders of bone development and growth	0.672	0.328
M89.1 Epiphyseal arrest	0.672	0.328
M89.0 Algoneurodystrophy	0.672	0.328
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.672	0.328
T16 Foreign body in ear	0.671	0.329
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.671	0.329
S63.4 Traumatic rupture of ligament of finger at metacarpophalangeal and interphalangeal joint(s)	0.670	0.330
C90 Multiple myeloma and malignant plasma cell neoplasms	0.670	0.330
M94 Other disorders of cartilage	0.669	0.331
W49 Exposure to other and unspecified inanimate mechanical forces	0.669	0.331
W21 Striking against or struck by sports equipment	0.668	0.332
M77.4 Metatarsalgia	0.668	0.332
T17 Foreign body in respiratory tract	0.667	0.333
C10 Malignant neoplasm of oropharynx	0.667	0.333
F43 Reaction to severe stress, and adjustment disorders	0.667	0.333
T43.0 Tricyclic and tetracyclic antidepressants	0.666	0.333
F32.8 Other depressive episodes	0.666	0.334
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.666	0.334
G20 Parkinson's disease	0.666	0.334
T18.9 Foreign body in alimentary tract, part unspecified	0.666	0.334
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.666	0.334
S62.8 Fracture of other and unspecified parts of wrist and hand	0.665	0.334
S62.2 Fracture of first metacarpal bone	0.665	0.335
C44.0 Skin of lip	0.665	0.335
X20-X29 Contact with venomous animals and plants	0.665	0.335
G30 Alzheimer's disease	0.665	0.335
M77.12 Lateral epicondylitis (Upper arm)	0.665	0.335
M77.02 Medial epicondylitis (Upper arm)	0.665	0.335
C17.0 Duodenum	0.664	0.336
G64 Other disorders of peripheral nervous system	0.663	0.336
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.663	0.337
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.663	0.337
T42.5 Mixed antiepileptics, not elsewhere classified	0.663	0.337
T42.3 Barbiturates	0.663	0.337
T42.2 Succinimides and oxazolidinediones	0.663	0.337
T42.0 Hydantoin derivatives	0.663	0.337
M46.4 Discitis, unspecified	0.663	0.337
G41.9 Status epilepticus, unspecified	0.662	0.338
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.662	0.338
Y51 Drugs primarily affecting the autonomic nervous system	0.660	0.340
S30 Superficial injury of abdomen, lower back and pelvis	0.659	0.340
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.659	0.341
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.658	0.341
S48 Traumatic amputation of shoulder and upper arm	0.658	0.342
S45 Injury of blood vessels at shoulder and upper arm level	0.658	0.342
S44 Injury of nerves at shoulder and upper arm level	0.658	0.342
S47 Crushing injury of shoulder and upper arm	0.658	0.342
M79.00 Rheumatism, unspecified (Multiple sites)	0.658	0.342
S62.4 Multiple fractures of metacarpal bones	0.658	0.342
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.658	0.342
Y49 Psychotropic drugs, not elsewhere classified	0.657	0.343
N60-N64 Disorders of breast	0.656	0.344
C22.9 Liver, unspecified	0.654	0.345
M93 Other osteochondropathies	0.654	0.346
W22.8 Other specified place	0.654	0.346
W22.6 Industrial and construction area	0.654	0.346
W22.4 Street and highway	0.654	0.346
W22.0 Home	0.654	0.346
W22.7 Farm	0.654	0.346
W22.5 Trade and service area	0.654	0.346
W22.3 Sports and athletics area	0.654	0.346
W22.2 School, other institution and public administrative area	0.654	0.346
W22.1 Residential institution	0.654	0.346
G37.8 Other specified demyelinating diseases of central nervous system	0.653	0.346
G37.5 Concentric sclerosis [Balo]	0.653	0.346
G37.4 Subacute necrotising myelitis	0.653	0.346
G37.2 Central pontine myelinolysis	0.653	0.346
G37.1 Central demyelination of corpus callosum	0.653	0.346
G37.0 Diffuse sclerosis	0.653	0.346
L81.4 Other melanin hyperpigmentation	0.653	0.347
C77.0 Lymph nodes of head, face and neck	0.652	0.348
F30.8 Other manic episodes	0.651	0.349
F30.1 Mania without psychotic symptoms	0.651	0.349
L60-L75 Disorders of skin appendages	0.651	0.349
C44.5 Skin of trunk	0.650	0.350
F30.0 Hypomania	0.650	0.350
T36.0 Penicillins	0.649	0.351
M87.8 Other osteonecrosis	0.649	0.351
C79.6 Secondary malignant neoplasm of ovary	0.649	0.351
G23 Other degenerative diseases of basal ganglia	0.648	0.352
G21 Secondary Parkinsonism	0.648	0.352
G26 Extrapyramidal and movement disorders in diseases classified elsewhere	0.648	0.352
G22 Parkinsonism in diseases classified elsewhere	0.648	0.352
C44.2 Skin of ear and external auricular canal	0.648	0.352
C80 Malignant neoplasm without specification of site	0.647	0.353
T19 Foreign body in genito-urinary tract	0.647	0.353
T15 Foreign body on external eye	0.647	0.353
C65 Malignant neoplasm of renal pelvis	0.647	0.353
C79.9 Secondary malignant neoplasm, unspecified site	0.646	0.354
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.645	0.355
M47.89 Other spondylosis (Site unspecified)	0.645	0.355
N13.3 Other and unspecified hydronephrosis	0.645	0.355
S60 Superficial injury of wrist and hand	0.645	0.355
M00 Pyogenic arthritis	0.644	0.356
S10 Superficial injury of neck	0.644	0.356
Y44 Agents primarily affecting blood constituents	0.644	0.356
C04 Malignant neoplasm of floor of mouth	0.644	0.356
C18.3 Hepatic flexure	0.643	0.357
C02.9 Tongue, unspecified	0.642	0.358
W50 Hit, struck, kicked, twisted, bitten or scratched by another person	0.642	0.358
S42.4 Fracture of lower end of humerus	0.642	0.358
M77.5 Other enthesopathy of foot	0.641	0.359
G73 Disorders of myoneural junction and muscle in diseases classified elsewhere	0.641	0.359
M79.19 Myalgia (Site unspecified)	0.641	0.359
F44 Dissociative [conversion] disorders	0.640	0.359
V80-V89 Other land transport accidents	0.640	0.360
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.640	0.360
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)	0.639	0.361
M62.88 Other specified disorders of muscle (Other)	0.639	0.361
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.639	0.361
T46.8 Antivaricose drugs, including sclerosing agents	0.639	0.361
T46.7 Peripheral vasodilators	0.639	0.361
T46.5 Other antihypertensive drugs, not elsewhere classified	0.639	0.361
T46.3 Coronary vasodilators, not elsewhere classified	0.639	0.361

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations